The mean (SD) cTnT level in the ALS samples was 35.99 pg/ml (±62.4), significantly higher than in controls (5.7 pg/ml ± 4.4 SD) or Alzheimer’s disease (12.05 pg/ml ± 16.3) (Fig. 1A). This evidence concerns the gene TNNT2 and early-onset autosomal dominant Alzheimer disease.